U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07204262) titled 'Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma' on Sept. 24.
Brief Summary: To evaluate whether tracking changes in key blood markers over time, together with clinical features, can improve the prediction of outcomes in patients with hepatocellular carcinoma (HCC). By developing a trajectory-based prognostic model, we aim to provide more accurate risk assessment and support personalized treatment decisions.
Study Start Date: Jan. 01, 2018
Study Type: OBSERVATIONAL
Condition:
Liver Cancer
Intervention:
COMBINATION_PRODUCT: Molecular Targeted Therapy (TKI / anti-VEGF antibody) PD-(L)1 Inhibitor Immunotherapy Int...